Ozempic vs Mounjaro: Which GLP-1 Is Right for You? (2026 Guide)

If you're researching GLP-1 medications for weight loss, you've almost certainly run into both Ozempic (semaglutide) and Mounjaro (tirzepatide). They're the two most widely prescribed injectables in this category, they're both weekly injections, and they both produce meaningful weight loss. So how do you choose?

This guide cuts through the comparison. We'll look at the mechanism of action (GLP-1 vs dual GIP/GLP-1), clinical trial results (STEP vs SURMOUNT programs), side effect profiles, dosing, and cost — so you have the data to have a better conversation with your provider.

Head-to-Head: Ozempic vs Mounjaro at a Glance

Brand list prices are approximate 2026 retail without insurance. Compounded costs from registered 503B pharmacies — requires prescription. Weight loss percentages are from 68-week clinical trial data (STEP program for semaglutide, SURMOUNT for tirzepatide).

How Ozempic Works: GLP-1 Receptor Agonist

Semaglutide (Ozempic, Wegovy) is a GLP-1 receptor agonist — it mimics the glucagon-like peptide-1 hormone that your gut naturally produces after eating. GLP-1 has three primary effects:

• Signals satiety to the brain. GLP-1 activates appetite-control centers in the hypothalamus, reducing hunger and food-seeking behavior. Patients describe this as their brain "quieting down" around food.
• Slows gastric emptying. Food stays in your stomach longer, extending the feeling of fullness after a meal. This is also why nausea is the most common side effect — a full stomach that empties slowly can feel uncomfortable.
• Regulates insulin. GLP-1 stimulates insulin secretion when blood sugar is elevated and suppresses glucagon — making Ozempic effective for both weight management and type 2 diabetes.

The clinical impact of these mechanisms is substantial. The STEP 1 trial (2,000 patients, 68 weeks) showed an average 14.9% body weight reduction at the highest semaglutide dose (2.4mg/week). For a 220-pound person, that's roughly 33 pounds lost. No other prescription medication produces results in this range.

How Mounjaro Works: Dual GIP/GLP-1 Agonist

Tirzepatide (Mounjaro, Zepbound) works on two receptor pathways simultaneously: GLP-1 (as above) and GIP (glucose-dependent insulinotropic polypeptide). GIP is another gut hormone that regulates insulin and affects energy metabolism.

The dual mechanism is the meaningful difference. By activating both receptors, tirzepatide appears to produce greater appetite suppression and metabolic effect than GLP-1 alone. The SURMOUNT-1 trial showed an average 20.9% body weight reduction at the highest dose (15mg/week) — versus 14.9% for semaglutide in comparable trial conditions.

Some patients also report that tirzepatide produces a qualitatively different appetite effect than semaglutide — less of the "food aversion" feeling and more of a clean reduction in hunger drive. This isn't universal, but it's reported frequently enough in clinical practice to be worth noting.

Clinical Trial Results: STEP vs SURMOUNT

Head-to-head comparison between semaglutide and tirzepatide is limited — there hasn't been a large, randomized trial directly comparing them. But the respective trial programs are the best available evidence:

Semaglutide — STEP Program Results

• STEP 1: 14.9% average weight reduction at 2.4mg/week over 68 weeks (2,000 patients)
• STEP 2: 10.6% weight reduction in patients with type 2 diabetes over 68 weeks
• STEP 3: 16% weight reduction with intensive behavioral therapy over 68 weeks
• STEP 4: Sustained weight loss over 2 years with continued treatment
• SELECT: 17,604 patients with established cardiovascular disease — significant reduction in major cardiovascular events (heart attack, stroke, cardiovascular death) over 3.3-year follow-up

Tirzepatide — SURMOUNT Program Results

• SURMOUNT-1: 20.9% average weight reduction at 15mg/week over 72 weeks (2,500 patients without diabetes)
• SURMOUNT-2: 15.7% weight reduction in patients with type 2 diabetes over 72 weeks
• SURMOUNT-3: 22.9% weight reduction after intensive lifestyle intervention followed by tirzepatide
• SURMOUNT-4: 26.6% average weight reduction over 88 weeks (including 16-week lifestyle intervention lead-in)

For context: 20% of a 220-pound person is 44 pounds. The clinical significance of this difference (15% vs 20–22%) depends on your starting point, goals, and how you respond to the medication. Some patients lose more on semaglutide than tirzepatide and vice versa — individual variation is substantial.

Side Effect Comparison: Ozempic vs Mounjaro

The side effect profiles are broadly similar — both are GLP-1 receptor agonists and share the same underlying mechanism. But there are clinically meaningful differences:

Percentages are approximate ranges from clinical trial data. Individual experience varies. The titration schedule (built into both protocols) significantly reduces GI side effects for most patients.

For a full breakdown of side effect management and the titration schedule, see our GLP-1 side effects and safety guide.

Cost Comparison: Ozempic vs Mounjaro

Both medications are expensive at brand-name list price without insurance. Here's how the costs break down in 2026:

For a full breakdown including manufacturer coupons, insurance nuances, and telehealth platform comparisons, see our GLP-1 cost comparison guide.

Which Is Right for You? A Decision Framework

The choice between semaglutide and tirzepatide depends on several factors. Here's how to think through it:

Choose Semaglutide (Ozempic) if:

• You want the medication with the longest real-world safety track record (8+ years of post-market data)
• You've previously tried other GLP-1 medications and want to start with the most established option
• You have type 2 diabetes and may benefit from semaglutide's strong diabetes management data
• You've had success with semaglutide previously and want to continue on the same pathway
• Cost is a primary factor — compounded semaglutide is slightly less expensive than compounded tirzepatide

Choose Tirzepatide (Mounjaro) if:

• You've tried semaglutide without reaching your target weight loss
• You want the option with the highest clinical trial weight loss results (20–22% vs 15%)
• You've found semaglutide's nausea difficult to tolerate — tirzepatide has lower nausea rates
• Your provider specifically recommends it based on your health profile and goals

Either is a valid choice if:

• You meet BMI qualifications (≥30 or ≥27 with a weight-related condition)
• You have no contraindications (thyroid cancer history, pancreatitis, pregnancy)
• You're committed to a long-term treatment plan including dietary adjustments

The most important factor is consistency — staying on the medication long enough to reach therapeutic effect. The difference between semaglutide and tirzepatide matters far less than the difference between starting either and never starting at all.

How to Get Started with Either Medication

Getting a GLP-1 prescription through Curapath is straightforward. The process is the same regardless of whether you and your provider decide on semaglutide or tirzepatide:

1. Complete your intake online. About 10 minutes covering your medical history, current medications, weight history, and goals. No scheduling, no waiting room.
2. Provider reviews and responds within 24 hours. A licensed provider in your state evaluates your case and makes a prescribing decision.
3. Prescription goes to your pharmacy. If approved, the prescription goes wherever you choose — retail pharmacy, mail-order, or 503B compounding pharmacy for lower cost.
4. Start your titration. Both semaglutide and tirzepatide have structured titration schedules. Follow yours and communicate any significant side effects to your provider.

See our GLP-1 telehealth consultation guide for the full walkthrough of what to expect.

Frequently Asked Questions

Is Ozempic or Mounjaro more effective for weight loss?

Head-to-head comparison trials haven't been conducted, but indirect comparison of clinical trial data suggests Mounjaro (tirzepatide) produces slightly greater average weight loss — roughly 20–22% body weight reduction vs 15% for Ozempic (semaglutide) at maximum doses. However, individual response varies substantially. Some patients lose more on semaglutide than tirzepatide, and vice versa. Both are substantially more effective than older weight-loss medications.

Can I switch from Ozempic to Mounjaro?

Yes — if you're not reaching your target weight loss on semaglutide, or if you're having difficulty tolerating side effects, switching to tirzepatide is a legitimate clinical approach. There's no mandatory washout period, though your provider will determine the appropriate starting dose for the new medication. Many patients who didn't achieve their goals on 2.4mg semaglutide reach those goals on tirzepatide.

How do the side effects of Ozempic and Mounjaro differ?

The overall side effect burden is similar. Key differences: Mounjaro has lower nausea rates (17–31% vs 20–44%) but higher diarrhea rates (20–22% vs 8–12%). Ozempic has higher constipation rates. Both require titration schedules designed to minimize GI side effects. Severe GI symptoms that prevent you from eating or drinking adequately warrant contacting your provider — the dose may need adjustment.

Does insurance cover Ozempic or Mounjaro for weight loss?

Insurance coverage for GLP-1 weight-loss medications is inconsistent. Most commercial plans cover Ozempic and Mounjaro for their diabetes indications. Coverage for weight loss (Wegovy, Zepbound) is less common and varies by employer. Medicare is prohibited from covering weight-loss drugs. Even when covered, prior authorization is typically required and denial rates are high. Many patients without coverage use compounded formulations to access these medications at a fraction of brand-name cost.

Is compounded semaglutide the same as Ozempic?

Compounded semaglutide from a registered 503B outsourcing facility contains the same active ingredient (semaglutide) as Ozempic and Wegovy. It is not the same as a brand-name product — it hasn't gone through the FDA's new drug approval process, and quality varies by pharmacy. Reputable 503B facilities follow CGMP standards. The key advantage is cost: $149–$250/month vs $936–$1,349/month for brand-name. A Curapath provider can write a prescription for compounded semaglutide or tirzepatide if clinically appropriate.

Can I use Ozempic for weight loss if I don't have diabetes?

Yes — Ozempic is FDA-approved for type 2 diabetes, and Wegovy (same active ingredient, different brand) is FDA-approved specifically for weight loss. Providers commonly prescribe semaglutide off-label for weight management when clinically appropriate, and telehealth platforms like Curapath offer this as a standard service. Mounjaro follows the same pattern — Zepbound is the FDA-approved weight-loss formulation of tirzepatide.

How long do I need to stay on Ozempic or Mounjaro?

GLP-1 medications are designed for long-term use. Clinical trials demonstrate sustained weight loss as long as the medication is continued. When stopped, appetite returns and most patients regain weight — typically within weeks of discontinuation. The clinical consensus is that these medications should be continued as long as they're providing benefit and you don't develop contraindications. Your provider will discuss your long-term treatment plan as part of the consultation.

Which has fewer side effects — Ozempic or Mounjaro?

Neither has an overall "fewer side effects" profile — they differ in which side effects are more common. Ozempic has higher nausea and constipation; Mounjaro has higher diarrhea. For most patients, the titration schedule makes early side effects manageable. If you've had significant nausea on Ozempic, switching to Mounjaro is worth discussing with your provider — the dual-receptor mechanism may produce a different tolerability profile for you. Your provider is the right person to evaluate your specific history and make a recommendation.

Related reading: GLP-1 Side Effects & Safety Guide — full breakdown of what to expect on either medication, titration schedules, and red flags. · GLP-1 Telehealth Consultation: What to Expect — step-by-step from intake to prescription. · GLP-1 Cost Comparison Guide (2026) — brand vs. compounded pricing across every major option.

Have questions about whether GLP-1 telehealth is right for you? Start your intake and our provider team will evaluate your specific situation. See also our GLP-1 cost comparison guide or our full range of telehealth services including men's health and women's health consultations.